MARKET

TLSIW

TLSIW

TriSalus Life Sciences Inc.
NASDAQ
0.9000
0.00
0.00%
Opening 09:30 08/28 EDT
OPEN
--
PREV CLOSE
0.9000
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
2.190
52 WEEK LOW
0.4405
MARKET CAP
--
P/E (TTM)
-0.6954
1D
5D
1M
3M
1Y
5Y
1D
TriSalus Life Sciences: Buy Rating Reaffirmed with Unchanged $7 Price Target Despite Near-Term Covenant Risks
TipRanks · 1d ago
Weekly Report: what happened at TLSI last week (0817-0821)?
Weekly Report · 4d ago
Weekly Report: what happened at TLSI last week (0810-0814)?
Weekly Report · 08/17 09:34
Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Spyre Therapeutics (SYRE) and IDEAYA Biosciences (IDYA)
TipRanks · 08/11 12:10
Analyst Justin Walsh Reaffirms Buy on TriSalus After Strong Q2 Results, CMS Reimbursement Tailwinds, and Growth Outlook Through 2026
TipRanks · 08/10 16:25
TriSalus Buy Rating Reiterated as Strong Q2 and Growth Catalysts Support Unchanged $7 Price Target
TipRanks · 08/10 11:55
Weekly Report: what happened at TLSI last week (0803-0807)?
Weekly Report · 08/10 09:32
Wasatch Micro Cap Fund Q2 2026 Contributors And Detractors
Seeking Alpha · 08/07 05:20
More
About TLSIW
TriSalus Life Sciences, Inc. is an oncology-focused medical technology company. It is seeking to transform outcomes for patients with solid tumors by integrating its delivery technology with standard-of-care therapies, and with its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 agonist, for a range of different therapeutic and technological applications. Its delivery method, Pressure-Enabled Drug Delivery (PEDD), modulates pressure and flow within blood vessels to improve intravascular therapeutic delivery into tumors, thereby increasing the likelihood of tumor response in comparison to conventional delivery technologies. Its on-market TriNav Infusion System using PEDD technology, is being used for interventional radiology procedures, commonly transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or in patients with liver metastases. TriNav is a device with a novel (PEDD) delivery method.

Webull offers TriSalus Life Sciences Inc stock information, including NASDAQ: TLSIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLSIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLSIW stock methods without spending real money on the virtual paper trading platform.